In all species studied to date, growth hormone (GH) is released episodicall
y. Traditionally, the regulation of this process was considered to be media
ted by two hypothalamic hormones, growth hormone-releasing hormone (GHRH) a
nd somatostatin (sst). More recently, we identified a new orphan G-protein-
coupled receptor that causes episodic GH release upon activation by synthet
ic ligands. These ligands include the GH-releasing peptides (GHRPs) first d
escribed by Bowers and their small molecule mimetics such as L-692,429 and
MK-0677. Site-directed mutagenesis of this GH secretagogue receptor (GHS-R)
has defined key amino acid residues essential for binding and activation b
y the synthetic ligands. The GHS-R is not activated by GHRH or sst. It is e
xpressed exclusively in the anterior pituitary lobe and central nervous sys
tem and although this new receptor does not belong to any of the known fami
lies of G-protein-coupled receptors, the GHS-R is highly conserved across s
pecies. The Puffer fish homolog in common with the human GHS-R, is activate
d by the structurally distinct ligands GHRP-6, MK-0677 and L-163, 540. Thus
, the GHS-R ligand-binding pocket has apparently been conserved for at leas
t 400 million years. Studies in humans suggest that production of an endoge
nous ligand declines during aging. For example, chronic treatment with the
synthetic ligand MK-0677 reverses the age-related physiological changes in
the GH/IGF-I (insulin-like growth factor I) axis of 70-94 year old subjects
. Based on the localization of expression of GHS-R in the brain, reduced pr
oduction of the natural ligand might also be involved in age-associated cha
nges in cognition, memory, mood and behavior.